drugset / Trial / NCT06908356

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

NCT06908356 ↗

Phase 2 Recruiting 50 enrolled Praxis Precision Medicines
NaSingle-groupOpen-labelTreatment

Summary

An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients With Focal Onset or Primary Generalized Tonic-Clonic Seizures

Timeline

Start
2025-01-10
Primary completion
2025-07
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PRAX-628 Unknown 30 mg Oral